Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001193125-25-284935

Chief Operating Officer sold 131,411 shares at an average $16.04 ($2,108,067)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bensen Daniel · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-13 Sale : show line 1 in the form 10b5-1 −1,111 $16.00 $17,780 426,870 D
2025-11-14 Sale : show line 2 in the form 10b5-1 −110,228 $16.02 $1,765,489 316,642 D
2025-11-17 Sale : show line 3 in the form 10b5-1 −18,572 $16.11 $299,191 298,070 D
2025-11-17 Sale : show line 4 in the form 10b5-1 −1,500 $17.07 $25,607 296,570 D
Open-market sales · 131,411 sh · avg $16.04 · $2,108,067
Loading xslF345X05/ownership.xml…